KALA
Kala Bio, Inc.
$0.12+0.00 (0.00%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Kala Pharmaceuticals, Inc. (KALA) is a publicly traded company with no SEC Form 4 insider transactions reported in the past 90 days. Form 4 filings disclose insider stock activity within two business days. The absence of recent filings can reflect either a stable insider holding pattern or simply no recent transactions to report. Historical filings, if any, remain searchable below.
Latest Insider Transactions
Showing 10 of 34 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-22 | 2025-12-18 | Lazar David E. | CEO | Other | 368,614 | $0.00 | $0 | N/A | N/A |
| 2025-10-24 | 2025-10-23 | Iwicki Mark T | Director | Sale | 154,894 | $0.81 | -$125,464 | N/A | N/A |
| 2025-10-24 | 2025-10-23 | Reumuth Mary | CFO | Sale | 967 | $0.82 | -$793 | N/A | N/A |
| 2025-10-24 | 2025-10-22 | Kharabi Darius | CBO | Sale | 20,806 | $0.83 | -$17,269 | N/A | N/A |
| 2025-10-24 | 2025-10-22 | Reumuth Mary | CFO | Sale | 32,230 | $0.83 | -$26,751 | N/A | N/A |
| 2025-10-24 | 2025-10-22 | Brazzell Romulus K | SEE REMARKS | Sale | 46,748 | $0.83 | -$38,801 | N/A | N/A |
| 2025-10-24 | 2025-10-22 | Bazemore Todd | Director | Sale | 47,768 | $0.83 | -$39,647 | N/A | N/A |
| 2025-10-02 | 2025-10-01 | Baker Bros. Advisors Lp | Other | Sale | 50,640 | $1.38 | -$70,086 | N/A | N/A |
| 2025-10-02 | 2025-10-01 | Baker Bros. Advisors Lp | Other | Sale | 462,967 | $1.38 | -$640,746 | N/A | N/A |
| 2025-10-02 | 2025-09-30 | Baker Bros. Advisors Lp | Other | Sale | 195,425 | $1.60 | -$311,898 | N/A | N/A |
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.